Cargando…

Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics

Glioblastoma (GBM) is the most aggressive malignant brain tumour, with a median survival of 3 months without treatment and 15 months with treatment. Early GBM diagnosis can significantly improve patient survival due to early treatment and management procedures. Magnetic resonance imaging (MRI) using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zijun, Dai, Lixiong, Tang, Ke, Ma, Yiqi, Song, Bin, Zhang, Yanrong, Li, Jinxing, Lui, Su, Gong, Qiyong, Wu, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634494/ https://www.ncbi.nlm.nih.gov/pubmed/34868634 http://dx.doi.org/10.1093/rb/rbab062

Ejemplares similares

Theranostics and contrast agents for magnetic resonance imaging
por: Jeong, Yohan, et al.
Publicado: (2018)

Retro-enantio isomer of angiopep-2 assists nanoprobes across the blood-brain barrier for targeted magnetic resonance/fluorescence imaging of glioblastoma
por: Xie, Ruoxi, et al.
Publicado: (2021)

Nitroxyl Radical as a Theranostic Contrast Agent in Magnetic Resonance Redox Imaging
por: Matsumoto, Ken-ichiro, et al.
Publicado: (2022)

Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
por: Zhuang, Danping, et al.
Publicado: (2022)

Nanomaterials incorporated ultrasound contrast agents for cancer theranostics
por: Fu, Lei, et al.
Publicado: (2016)

Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Li, Yan, et al.
Publicado: (2021)

pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents
por: Huang, Xi, et al.
Publicado: (2018)

Theranostic Applications of an Ultra-Sensitive T(1) and T(2) Magnetic Resonance Contrast Agent Based on Cobalt Ferrite Spinel Nanoparticles
por: Mikhaylov, Georgy, et al.
Publicado: (2022)

Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
por: Li, Yan, et al.
Publicado: (2021)

Contrast agents in dynamic contrast-enhanced magnetic resonance imaging
por: Yan, Yuling, et al.
Publicado: (2017)

Magnetic Resonance Neuroimaging Contrast Agents of Nanomaterials
por: Guo, Longjun, et al.
Publicado: (2022)

Advances in the Radiological Evaluation of and Theranostics for Glioblastoma
por: Hooper, Grayson W., et al.
Publicado: (2023)

Dynamically switchable magnetic resonance imaging contrast agents
por: Wang, Qiyue, et al.
Publicado: (2021)

Contrast Agents of Magnetic Resonance Imaging and Future Perspective
por: Lv, Jie, et al.
Publicado: (2023)

Retracted: Magnetic Resonance Neuroimaging Contrast Agents of Nanomaterials
por: International, BioMed Research
Publicado: (2023)

Ultrasound contrast agent loaded with nitric oxide as a theranostic microdevice
por: Grishenkov, Dmitry, et al.
Publicado: (2015)

Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications
por: Longo, Dario Livio, et al.
Publicado: (2017)

Multifunctionalized Microscale Ultrasound Contrast Agents for Precise Theranostics of Malignant Tumors
por: Fu, Jia-Wei, et al.
Publicado: (2019)

Smart magnetic resonance imaging-based theranostics for cancer
por: Brito, Beatriz, et al.
Publicado: (2021)

Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems
por: Rudakovskaya, Polina G., et al.
Publicado: (2022)

T(1)–T(2) molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents
por: Li, Jingjing, et al.
Publicado: (2018)

Biomineral Nano-Theranostic agent for Magnetic Resonance Image Guided, Augmented Radiofrequency Ablation of Liver Tumor
por: Ashokan, Anusha, et al.
Publicado: (2017)

Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study
por: Ferrari, Cristina, et al.
Publicado: (2015)

Magnetosomes Extracted from Magnetospirillum gryphiswaldense as Theranostic Agents in an Experimental Model of Glioblastoma
por: Mannucci, Silvia, et al.
Publicado: (2018)

High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients
por: Wu, Zijun, et al.
Publicado: (2021)

Evaluation of Microbubbles as Contrast Agents for Ultrasonography and Magnetic Resonance Imaging
por: Li, Ling, et al.
Publicado: (2012)

Activatable T(1) and T(2) Magnetic Resonance Imaging Contrast Agents
por: Tu, Chuqiao, et al.
Publicado: (2011)

Use of contrast agents in oncological imaging: magnetic resonance imaging
por: Morana, Giovanni, et al.
Publicado: (2013)

Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging
por: Pellico, Juan, et al.
Publicado: (2019)

Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics
por: Gan, Shenglong, et al.
Publicado: (2018)

Glioblastoma Presenting with Steroid-Induced Pseudoregression of Contrast Enhancement on Magnetic Resonance Imaging
por: Mazur, Marcus D., et al.
Publicado: (2012)

Correlation between contrast enhancement on intraoperative magnetic resonance imaging and histopathology in glioblastoma
por: Kubben, Pieter L., et al.
Publicado: (2012)

Advanced Radio Frequency Applicators for Thermal Magnetic Resonance Theranostics of Brain Tumors
por: Saha, Nandita, et al.
Publicado: (2023)

The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances
por: Li, Xiaodong, et al.
Publicado: (2020)

A new pH/NIR responsive theranostic agent for magnetic resonance imaging guided synergistic therapy
por: Du, Yechao, et al.
Publicado: (2021)

Theranostic nanoparticles enhance the response of glioblastomas to radiation
por: Wu, Wei, et al.
Publicado: (2019)

Recent Advances in Imaging Agents Anchored with pH (Low) Insertion Peptides for Cancer Theranostics
por: Liu, Yu-Cheng, et al.
Publicado: (2023)

Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics
por: Ray, Sayoni, et al.
Publicado: (2018)

Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer
por: Li, Yanan, et al.
Publicado: (2020)

Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
por: Estelrich, Joan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_chddtqkg8g2kv1jh60eqnlsn0n